Expression of Cyclooxygenase-2 and Its Correlation with Clinicopathologic Factors of Ampulla of Vater Cancer

Journal of Korean Medical Science

Volumn 18, Issue 2, 2003, Pages 218-224

  Kim, Hong Joo ^a   Sohn, Tae Sung ^a   Lee, Kyu Taek ^a   Lee, Jong Kyun ^a   Paik, Seung Woon ^a   Rhee, Jong Chul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Antigen cd34; Apoptosis; Duodenal neoplasms; Ki 67 antigen; Prostaglandin endoperoxide synthase; Vater's ampulla

Indexed keywords

CD34 ANTIGEN; CYCLOOXYGENASE 2; KI 67 ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; PROTEIN EXPRESSION; VATER PAPILLA CARCINOMA;

EID: 0348147400     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.2.218     Document Type: Article

References (38)

1. Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF. Factors predictive of survival in ampullary carcinoma. Ann Surg 1998; 228: 87-94.
2. Neoptolemos JP, Talbot IC, Shaw DC, Carr-Locke DL. Long-term survival after resection of ampullary carcinoma is associated independently with tumor grade and a new staging classification that assesses local invasiveness. Cancer 1998; 61: 1403-7.
3. Klempnauer J, Ridder GJ, Pichlmayr R. Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg 1995; 82: 1686-91.
4. Roder JD, Schneider PM, Stein HJ, Siewert JR. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 1995; 82: 1693-6.
5. Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, Verbeek PC, de Wit LT, Gouma DJ. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery 1995; 117: 247-53.
6. Shirai Y, Tsukada K, Ohtani T, Koyama G, Muto T, Watanabe H, Hatakeyama K. Carcinoma of the ampulla of Vater: histopathologic analysis of tumor spread in Whipple pancreatoduodenectomy specimens. World J Surg 1995; 19: 102-6.
7. Achille A, Biasi MO, Zamboni G, Bogina G, Iacono C, Talamini G, Capella G, Scarpa A. Cancers of the ampulla of Vater: mutator phenotype is associated with good prognosis. Clin Cancer Res 1997; 3: 1841-7.
8. Talamini MA, Moesinger RC, Pitt HA, Sohn TA, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225: 590-9.
9. Dorandeu A, Raoul JL, Siriser F, Leclercq-Rioux N, Gosslin M, Martin ED, Ramee Mp, Raunois B. Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases. Gut 1997; 40: 350-5.
10. Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Kijima H, Saito T. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the ampulla of Vater. Cancer 1999; 86: 596-607.
11. Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997; 100: 1325-9.
12. Smith CJ, Morrow JD, Roberts LJ, Marnett LJ. Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun 1993; 192: 787-93.
13. Smalley WE, DuBois RN. Colorectal cancer and non steroidal anti-inflammatory drugs. Adv Pharmacol 1997; 39: 1-20.
14. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325: 1593-6.
15. Khan KN, Masferrer JL, Woemer BM, Soslow R, Koki AT. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Scand J Gastroenterol 2001; 36: 865-9.
16. Wullen B, Muhlhofer A, Zoller WG. Effect of celecoxib, a COX-2 inhibitor, in familial adenomatous polyposis. Z Gastroenterol 2001; 39: 335-7.
17. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 2000; 60: 293-7.
18. Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET, Lubet RA. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryo. Cancer Res 2000; 60: 1864-70.
19. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 1996; 87: 803-9.
20. Vogiagis D, Brown W, Glare EM, O'Brien PE. Rat colorectal tumours treated with a range of non steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression level. Carcinogenesis 2001; 22: 869-74.
21. Bennett A, Civier A, Hensby CN, Melhuish PB, Stamford IF. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 1987; 28: 315-8.
22. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression on human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-8.
23. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 362-6.
24. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-16.
25. Marnett LJ. Aspirin and potential role of prostaglandins in colon cancer. Cancer Res 1992; 52: 5575-89.
26. Shiff SJ, Koutsos M, Qiao L, Rigas B. Nonsteroidal anti-inflammatory drugs inhibit the proliferarion of colon adenocarcinoma cells: Effects on cell cycle and apoptosis. Exp Cell Res 1996; 222: 179-88.
27. Mikkelson HB, Rumessen JJ, Qvortrup K. Prostaglandin H synthase immunoreactivity in human gut: an immunohistochemical study. Histochemistry 1991; 96: 295-9.
28. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-9.
29. Kokawa A, Kondo H, Gotoda T, Ono H, Saito D, Nakadaira S, Kosuge T, Yoshida S. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer 2001; 91: 333-8.
30. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric cancer. Cancer Res 1997; 57: 1276-80.
31. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998; 58: 2929-34.
32. Kargman SL, O'Neil GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995; 55: 2556-9.
33. Denkert C, Kobel M, Pest S, Koch I, Berger S, Schwabe M, Siegert A, Reles A, Klosterhalfen B, Hauptmann S. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 2002; 160: 893-903.
34. Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol 2002; 97: 1037-41.
35. Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Holscher AH, Danenberg KD, Danenberg PV. Prognostic significance of cyclooxygenase 2 mRNA expression in non small cell lung cancer. Ann Surg 2002; 235: 440-3.
36. Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC. Cyclooxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 2002; 55: 429-34.
37. Buskens CJ, van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, van Lanschot JJ, Ristimaki A. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 2002; 122: 1800-7.
38. Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 2002; 190: 279-86.